MacroGenics, Inc. (MGNX) is a publicly traded Healthcare sector company. As of September 13, 2026, MGNX trades at $4.01 with a market cap of $254.80M and a P/E ratio of -3.40. MGNX moved +1.01% today. Year to date, MGNX is +148.45%; over the trailing twelve months it is +142.42%. Its 52-week range spans $0.99 to $5.08. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces MGNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MGNX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.01 |
| Market Cap | $254.80M |
| P/E Ratio | -3.40 |
| EPS | $-1.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.08 |
| 52-Week Low | $0.99 |
| Volume | 320.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $149.50M |
| Net Income | $-74.62M |
| Gross Margin | 0.00% |
4 analysts cover MGNX: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.